Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ACH · Entity 6858 | EVP,General Counsel & CorpSecy | May 18, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 166,306 |
Reported balance
After 2026-05-18 transaction · row 1
1 source rowRow 1 · 2026-05-18 · Tax withholding · Disposed 1,822 · Balance 166,306 F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 20, 2026 12:31 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | Tax withholdingCommon Stock | 1,822 | $2.91 | $5,302.02 |
DisclosureSEC source: 0000075252-26-000038 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,306 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 15, 2026 Filed May 19, 2026 12:54 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | Tax withholdingCommon Stock | 966 | $3.04 | $2,936.64 |
DisclosureSEC source: 0000075252-26-000034 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,128 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 21:40 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | Tax withholdingCommon Stock | 9,347 | $2.03 | $18,974.41 |
DisclosureSEC source: 0000075252-26-000013 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,094 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 01:01 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | GrantCommon Stock | 61,437 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-26-000006 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,441 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| May 19, 2025 Filed May 20, 2025 23:55 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,768 | $7.38 | $13,047.84 |
DisclosureSEC source: 0001062993-25-009905 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,044 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:07 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,315 | $7.00 | $9,205.00 |
DisclosureSEC source: 0001062993-25-009647 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,772 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 23:43 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 2,734 | $10.09 | $27,586.06 |
DisclosureSEC source: 0001062993-25-006168 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,087 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:36 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 69,743 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004635 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,821 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| May 17, 2024 Filed May 20, 2024 12:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,768 | $19.11 | $33,786.48 |
DisclosureSEC source: 0001062993-24-010741 · form4.xml · nonDerivative · entry 3 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,078 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| May 17, 2024 Filed May 20, 2024 12:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,052 | $19.06 | $39,111.12 |
DisclosureSEC source: 0001062993-24-010741 · form4.xml · nonDerivative · entry 2 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,846 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| May 16, 2024 Filed May 20, 2024 12:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 2,031 | $20.18 | $40,985.58 |
DisclosureSEC source: 0001062993-24-010741 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,898 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 1,752 | $19.78 | $34,654.56 |
DisclosureSEC source: 0001062993-24-010492 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,929 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:52 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 24,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005536 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,681 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 107 | $19.96 | $2,135.72 |
DisclosureSEC source: 0001062993-24-002541 · form4.xml · nonDerivative · entry 2 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,330 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 21:01 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 97 | $19.91 | $1,931.27 |
DisclosureSEC source: 0001062993-24-002541 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,437 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| December 29, 2023 Filed Jan 18, 2024 13:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 55 | $16.18 | $890.12 |
DisclosureSEC source: 0001062993-24-000994 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,534 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 00:02 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 5,500 | $17.57 | $96,635.00 |
DisclosureSEC source: 0001062993-23-020716 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,479 F1 · kind: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective August 10, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 22:39 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 56 | $16.24 | $909.16 |
DisclosureSEC source: 0001062993-23-014517 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,979 F1 · kind: Shares acquired under the Owens & Minor Teammate Stock Purchase Plan in a transaction that was exempt under Rule 16b-3(c). Read SEC document |
| May 17, 2023 Filed May 19, 2023 11:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 17,794 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011735 · form4.xml · nonDerivative · entry 1 Galloway Heath H · CIK 0001976274 · EVP,General Counsel & CorpSecy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,923 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.